| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 12 1805-1813, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
M Jeffers, MS Rao, S Rulong, JK Reddy, V Subbarao, E Hudson, GF Vande Woude and JH Resau
Advanced BioScience Laboratories, Inc.-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702, USA.
Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector for cells expressing the Met tyrosine kinase receptor. In this investigation, we show that pancreatic oval cells express Met and exhibit a proliferative response to HGF/SF. Additionally, we found that oval cells treated transiently with this factor become "scattered," whereas those exposed to HGF/ SF for extended periods of time form branching tubular structures. These structures possess true lumens, which are lined by cells with ductal features, including apical microvilli, well-developed intercellular junctions, interdigitation of plasma membranes, and abundant cytoplasmic organelles. Interestingly, these ductal structures are formed by HGF/SF-treated cells cultured on plastic dishes in the absence of exogenous extracellular matrix components. Consistent with their ability to form ductal structures in vitro, we found that pancreatic oval cells form ductal adenocarcinomas in nude mice. This study supports the involvement of HGF/SF-Met signaling in the growth, migration, and morphogenesis of pancreatic oval cells and may have important implications for the expansion and morphogenic differentiation of these cells during developmental, regenerative, and neoplastic growth.
This article has been cited by other articles:
![]() |
G. del Castillo, V. M. Factor, M. Fernandez, A. Alvarez-Barrientos, I. Fabregat, S. S. Thorgeirsson, and A. Sanchez Deletion of the Met Tyrosine Kinase in Liver Progenitor Oval Cells Increases Sensitivity to Apoptosis in Vitro Am. J. Pathol., May 1, 2008; 172(5): 1238 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, S. T. Magness, R. Bataller, R. A. Rippe, and D. A. Brenner NF-{kappa}B activation in Kupffer cells after partial hepatectomy Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G530 - G538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beilmann, G. F. Vande Woude, H.-P. Dienes, and P. Schirmacher Hepatocyte growth factor-stimulated invasiveness of monocytes Blood, June 15, 2000; 95(12): 3964 - 3969. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hung and B. Elliott Co-operative Effect of c-Src Tyrosine Kinase and Stat3 in Activation of Hepatocyte Growth Factor Expression in Mammary Carcinoma Cells J. Biol. Chem., April 6, 2001; 276(15): 12395 - 12403. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-H. Xiao, M. Jeffers, A. Bellacosa, Y. Mitsuuchi, G. F. Vande Woude, and J. R. Testa Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways PNAS, January 2, 2001; 98(1): 247 - 252. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |